Balkwill F
Biological Therapy Laboratory, Imperial Cancer Research Fund, London, UK.
J Viral Hepat. 1998 Jan;5(1):1-14. doi: 10.1046/j.1365-2893.1998.00081.x.
Chemokines are the largest mammalian cytokine family so far identified. They have distinct molecular structures and are unique among the cytokines in their chemotactic properties and ability to inhibit bone marrow progenitor-cell growth. A wealth of in vitro and in vivo data show that chemokines act as directional forces in immune and inflammatory responses, working with integrins to target subsets of effector cells to specific tissue sites. The selective action of individual chemokines on leucocyte subsets makes them ideal molecules to sort, as well as direct, leucocyte traffic. In addition to their in vitro and in vivo actions on haemopoietic precursors, chemokines can also modulate angiogenesis and some may activate leucocytes. There is still much to learn about the chemokines and their intracellular pathways, and more ligands and receptors will undoubtedly be discovered. However, chemokines are already known to be central to the co-ordination of leucocyte responses and represent important therapeutic targets in a number of diseases.
趋化因子是目前已鉴定出的最大的哺乳动物细胞因子家族。它们具有独特的分子结构,在细胞因子中,其趋化特性以及抑制骨髓祖细胞生长的能力是独一无二的。大量的体外和体内数据表明,趋化因子在免疫和炎症反应中充当定向力量,与整合素协同作用,将效应细胞亚群靶向特定的组织部位。单个趋化因子对白细胞亚群的选择性作用使其成为分选以及引导白细胞迁移的理想分子。除了对造血前体细胞的体外和体内作用外,趋化因子还可以调节血管生成,有些趋化因子可能激活白细胞。关于趋化因子及其细胞内途径仍有许多有待了解之处,无疑还会发现更多的配体和受体。然而,已知趋化因子在白细胞反应的协调中起着核心作用,并且是多种疾病中的重要治疗靶点。